MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 199 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $434,760 | -36.3% | 2,977 | +0.7% | 0.00% | -50.0% |
| Q2 2023 | $682,605 | +2.2% | 2,955 | +7.2% | 0.00% | 0.0% |
| Q1 2023 | $667,669 | -24.7% | 2,756 | -9.7% | 0.00% | -33.3% |
| Q4 2022 | $886,133 | +126.6% | 3,053 | -23.2% | 0.00% | +200.0% |
| Q1 2022 | $391,000 | -7.3% | 3,976 | -20.1% | 0.00% | 0.0% |
| Q4 2021 | $422,000 | +5.8% | 4,979 | -0.4% | 0.00% | 0.0% |
| Q3 2021 | $399,000 | -30.8% | 4,999 | -15.6% | 0.00% | -50.0% |
| Q2 2021 | $577,000 | +8.5% | 5,926 | +30.2% | 0.00% | 0.0% |
| Q1 2021 | $532,000 | +10.6% | 4,552 | +5.2% | 0.00% | 0.0% |
| Q4 2020 | $481,000 | +96.3% | 4,326 | +278.8% | 0.00% | 0.0% |
| Q3 2018 | $245,000 | +14.5% | 1,142 | +49.1% | 0.00% | +100.0% |
| Q2 2018 | $214,000 | – | 766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |